Benefit-Risk Analysis of Buprenorphine for Pain Management

Overview

Journal J Pain Res

Publisher Dove Medical Press

Date 2021 Jun 3

PMID 34079354

Citations 16

Authors

Martin Hale

Mark Garofoli

Robert B Raffa

Affiliations

Soon will be listed here.

Abstract

Health care providers in the United States are facing challenges in selecting appropriate medication for patients with acute and chronic pain in the midst of the current opioid crisis and COVID-19 pandemic. When compared with conventional opioids, the partial µ-opioid receptor agonist buprenorphine has unique pharmacologic properties that may be more desirable for pain management. The formulations of buprenorphine approved by the US Food and Drug Administration for pain management include intravenous injection, transdermal patch, and buccal film. A comparison of efficacy and safety data from studies of buprenorphine and conventional opioids suggests that buprenorphine may be a better-tolerated treatment option for many patients that provides similar or superior analgesia. Our benefit-risk assessment in this narrative review suggests that health care providers should consider that buprenorphine may be an appropriate alternative for pain management over other opioids.

Citing Articles

Efficacy and safety of sublingual buprenorphine in managing acute postoperative pain - A systematic review.

Nair A, Dudhedia U, Bodas P, Rangaiah M, Borkar N J Anaesthesiol Clin Pharmacol. 2025; 40(4):574-581.

PMID: 39759033 PMC: 11694887. DOI: 10.4103/joacp.joacp_245_23.

Pharmacological Pain Treatment in Older Persons.

Pickering G, Kotlinska-Lemieszek A, Krcevski Skvarc N, OMahony D, Monacelli F, Knaggs R Drugs Aging. 2024; 41(12):959-976.

PMID: 39465454 PMC: 11634925. DOI: 10.1007/s40266-024-01151-8.

Economic burden and dosing trends of buprenorphine buccal film and transdermal patch in chronic low back pain.

Zah V, Stanicic F, Vukicevic D, Grbic D Pain Manag. 2024; 14(4):195-207.

PMID: 38939964 PMC: 11229441. DOI: 10.1080/17581869.2024.2348989.

Buprenorphine Facilitates Rapid Weaning From Very-High-Dose Intrathecal Hydromorphone.

Hickey T, Manepalli A, Hitt J Cureus. 2024; 16(4):e59134.

PMID: 38803786 PMC: 11129534. DOI: 10.7759/cureus.59134.

Development and Validation of a Treatment Algorithm for Osteoarthritis Pain Management in Patients With End-Stage Kidney Disease Undergoing Hemodialysis.

Mohsen M, Feldberg J, Abbaticchio A, Jassal S, Battistella M Can J Kidney Health Dis. 2024; 11:20543581241249365.

PMID: 38746016 PMC: 11092542. DOI: 10.1177/20543581241249365.

References

Karp J, Butters M, Begley A, Miller M, Lenze E, Blumberger D . Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults. J Clin Psychiatry. 2014; 75(8):e785-93. PMC: 4157317. DOI: 10.4088/JCP.13m08725. View

Raffa R, Haidery M, Huang H, Kalladeen K, Lockstein D, Ono H . The clinical analgesic efficacy of buprenorphine. J Clin Pharm Ther. 2014; 39(6):577-83. DOI: 10.1111/jcpt.12196. View

Pergolizzi Jr J, Raffa R . Safety And Efficacy Of The Unique Opioid Buprenorphine For The Treatment Of Chronic Pain. J Pain Res. 2020; 12:3299-3317. PMC: 6917545. DOI: 10.2147/JPR.S231948. View

Malinoff H, Barkin R, Wilson G . Sublingual buprenorphine is effective in the treatment of chronic pain syndrome. Am J Ther. 2005; 12(5):379-84. DOI: 10.1097/01.mjt.0000160935.62883.ff. View

Robinson S . Buprenorphine: an analgesic with an expanding role in the treatment of opioid addiction. CNS Drug Rev. 2002; 8(4):377-90. PMC: 6741692. DOI: 10.1111/j.1527-3458.2002.tb00235.x. View

Hale M, Khan A, Kutch M, Li S . Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain. Curr Med Res Opin. 2010; 26(6):1505-18. DOI: 10.1185/03007995.2010.484723. View

MASSON A . Sublingual buprenorphine versus oral dihydrocodeine in post-operative pain. J Int Med Res. 1981; 9(6):506-10. DOI: 10.1177/030006058100900614. View

Rabinov M, Rosenfeldt F, McLean A . A double-blind comparison of the relative efficacy, side effects and cost of buprenorphine and morphine in patients after cardiac surgery. Aust N Z J Surg. 1987; 57(4):227-31. DOI: 10.1111/j.1445-2197.1987.tb01345.x. View

Serafini G, Adavastro G, Canepa G, de Berardis D, Valchera A, Pompili M . The Efficacy of Buprenorphine in Major Depression, Treatment-Resistant Depression and Suicidal Behavior: A Systematic Review. Int J Mol Sci. 2018; 19(8). PMC: 6121503. DOI: 10.3390/ijms19082410. View

10.

Chang K, Chang W, Chang W, Lin S, Chan K, Sung C . Comparison of intravenous patient-controlled analgesia with buprenorphine versus morphine after lumbar spinal fusion--a prospective randomized clinical trial. Acta Anaesthesiol Taiwan. 2006; 44(3):153-9. View

11.

Streltzer J, Davidson R, Goebert D . An observational study of buprenorphine treatment of the prescription opioid dependent pain patient. Am J Addict. 2015; 24(4):357-61. DOI: 10.1111/ajad.12198. View

12.

Gaitini L, Moskovitz B, Katz E, Vaisberg A, Vaida S, Nativ O . Sublingual buprenorphine compared to morphine delivered by a patient-controlled analgesia system as postoperative analgesia after prostatectomy. Urol Int. 1996; 57(4):227-9. DOI: 10.1159/000282920. View

13.

Schmidt-Hansen M, Bromham N, Taubert M, Arnold S, Hilgart J . Buprenorphine for treating cancer pain. Cochrane Database Syst Rev. 2015; (3):CD009596. PMC: 6513197. DOI: 10.1002/14651858.CD009596.pub4. View

14.

Rauck R, Nalamachu S, Wild J, Walker G, Robinson C, Davis C . Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study. Pain Med. 2014; 15(6):975-85. DOI: 10.1111/pme.12377. View

15.

Jakobs R, Adamek M, Von Bubnoff A, Riemann J . Buprenorphine or procaine for pain relief in acute pancreatitis. A prospective randomized study. Scand J Gastroenterol. 2001; 35(12):1319-23. DOI: 10.1080/003655200453692. View

16.

Oifa S, Sydoruk T, White I, Ekstein M, Marouani N, Chazan S . Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery. Clin Ther. 2009; 31(3):527-41. DOI: 10.1016/j.clinthera.2009.03.018. View

17.

Griessinger N, Sittl R, Likar R . Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin. 2005; 21(8):1147-56. DOI: 10.1185/030079905X53315. View

18.

Lazaridou A, Paschali M, Edwards R, Gilligan C . Is Buprenorphine Effective for Chronic Pain? A Systematic Review and Meta-analysis. Pain Med. 2020; 21(12):3691-3699. DOI: 10.1093/pm/pnaa089. View

19.

Bradley J . A comparison of morphine and buprenorphine for analgesia after abdominal surgery. Anaesth Intensive Care. 1984; 12(4):303-10. DOI: 10.1177/0310057X8401200403. View

20.

Dahan A, Yassen A, Romberg R, Sarton E, Teppema L, Olofsen E . Buprenorphine induces ceiling in respiratory depression but not in analgesia. Br J Anaesth. 2006; 96(5):627-32. DOI: 10.1093/bja/ael051. View